RMD Stock Analysis: Buy, Sell, or Hold?
RMD - ResMed Inc.
$203.87
-4.58 (-2.20%)
▼
5d:
-2.75%
30d:
+3.52%
90d:
-10.58%
BUY
HIGH Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 06, 2026
23d
Smart Money Distribution
None View Scanner →
Strength: 7.3/10
Get Alerted When RMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: RMD trading at deep discount. Market pricing in -4.5% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: RMD trading at deep discount. Market pricing in -4.5% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$317.52
Based on 6.3% avg growth
INTRINSIC VALUE TODAY
$197.15
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: RMD is currently trading at $203.87, which is considered slightly high relative to its 30-day fair value range of $188.00 to $205.85. From a valuation perspective, the stock is trading at a discount (Forward PE: 16.9) compared to its historical average (19.4). Remarkably, the market is currently pricing in an annual earnings decline of 4.5% over the next few years. This pessimistic expectation contrasts with the company's recent 10.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, RMD is in a strong downtrend. Immediate support is located at $192.81, while resistance sits at $222.43.
Market Sentiment: RMD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $257.07 (+26.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, RMD is in a strong downtrend. Immediate support is located at $192.81, while resistance sits at $222.43.
Market Sentiment: RMD has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $257.07 (+26.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$188.00 -
$205.85
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
76.2%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 26.1% below Wall St target ($257.07)
Trading Range Analysis
30-Day Trading Range
$188.00 -
$205.85
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$192.81
Resistance Level
$222.43
Current Trend
Strong Downtrend
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.90
Wall Street Target
$257.07
(+26.1%)
Revenue Growth (YoY)
10.8%
Earnings Growth (YoY)
10.5%
Profit Margin
27.4%
Valuation Discount vs History
-4.5% cheaper
PE vs Historical
16.9 vs 19.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.5%
(market-implied from PE analysis)
1-Year Target
$194.70
(-5%)
2-Year Target
$185.93
(-9%)
3-Year Target
$177.57
(-13%)
3-Yr Target (if PE normalizes)
(PE: 17→19)
$203.88
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 8.6%)
$336.77
(+65%)
Base:
(SPY PE: 16.9, Growth: 8.6%)
$261.26
(+28%)
Bear:
(PE: 14.4, Growth: 8.6%)
$222.07
(+9%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (17x PE) as earnings recover.
Trailing PE: 19.83 | Current EPS (TTM): $10.51
Bull Case
$263.24
(+29%)
Analyst growth 14.8%, PE expands to 21.8
Base Case
$239.31
(+17%)
Market implied 14.8%, PE stable at 19.8
Bear Case
$141.75
(-31%)
Severe decline -20.0%, PE contracts to 16.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 16.9 to 19.4
Stabilization Target:
$234.08
(+14.8%)
PE Expansion Potential:
+14.8%
Share & Embed Analysis
Last updated: July 13, 2026 7:07 AM ET
Data refreshes hourly during market hours. Next update: 8:07 AM
Data refreshes hourly during market hours. Next update: 8:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is RMD showing a specific setup today?
Insider Activity (6 Months)
1
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael J Farrell
SELL
4991 shares
2026-04-07
Peter C Farrell
SELL
2000 shares
2026-04-01
Ro Khanna
SELL
2026-03-30
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$562 | 62 BUY |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 60 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$177 | 55 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$366 | 63 BUY |
|
COO
The Cooper Companies, Inc |
BUY
19 analysts |
$81 | 62 BUY |
Advanced RMD Option Strategies
Professional options setups generated by AI based on today's RMD price and gamma walls.
